Page last updated: 2024-11-02

pantoprazole and Dysphonia

pantoprazole has been researched along with Dysphonia in 2 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Dysphonia: Difficulty and/or pain in PHONATION or speaking.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lechien, JR2
Huet, K2
Khalife, M2
Fourneau, AF2
Finck, C2
Delvaux, V2
Piccaluga, M2
Harmegnies, B2
Saussez, S2

Other Studies

2 other studies available for pantoprazole and Dysphonia

ArticleYear
Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study.
    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2018, Volume: 275, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Case-Control Studies; Dysphonia; Female; Hoarseness;

2018
Impact of Laryngopharyngeal Reflux on Subjective, Aerodynamic, and Acoustic Voice Assessments of Responder and Nonresponder Patients.
    Journal of voice : official journal of the Voice Foundation, 2019, Volume: 33, Issue:6

    Topics: Diet; Dysphonia; Female; Humans; Laryngopharyngeal Reflux; Male; Middle Aged; Pantoprazole; Phonatio

2019